Bioretec Ltd, a pioneer in bioresorbable orthopedic implants, announces that Dr. Jeremy Dublon joins the Bioretec team to support Company’s U.S. commercialization strategy from a clinical and regulatory perspective. Dr. Dublon joins the Bioretec team as a Regulatory Advisor.
Dr. Dublon is a board-certified podiatric surgeon specializing in diagnosing and treating conditions in the foot and ankle of people of all ages. In addition, he has specialized training and education in podiatric medicine, surgery, and orthopedics. Earlier, Dr. Dublon served at the U.S. Food and Drug Administration (FDA) on the review team as a Medical Officer in the Division of Restorative, Repair, and Trauma evaluating orthopedic products. Furthermore, he has served as a Deputy Service Chief at Walter Reed National Military Medical Center, where he led the Podiatry Department and acted as a White House Medical Consultant and Surgeon to the President.
As Bioretec’s Regulatory Advisor, Dr. Dublon participates extensively in supporting the company’s RemeOs™ trauma screw product launch, indication expansion, and commercialization from clinical and regulatory perspectives.
“We warmly welcome Dr. Dublon into our team with his extensive background from the field of orthopedics. His clinical expertise in foot and ankle surgery and his broad experience of the U.S. regulatory processes will strongly support our future success in the vast U.S. markets,” says Timo Lehtonen, CEO of Bioretec Ltd.
